Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Dec 16;25(1):432.
doi: 10.1186/s13054-021-03840-x.

Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study

A Ceccato  1 , A Russo  2 , E Barbeta  1   3 , P Oscanoa  1   3 , G Tiseo  4 , A Gabarrus  1   3 , P Di Giannatale  5 , S Nogas  6 , C Cilloniz  1   3 , F Menichetti  4 , M Ferrer  1   3 , M Niederman  7 , M Falcone  4 , A Torres  8   9
Affiliations
Observational Study

Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study

A Ceccato et al. Crit Care. .

Abstract

Background: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide despite correct antibiotic use. Corticosteroids have long been evaluated as a treatment option, but heterogeneous effects on survival have precluded their widespread implementation. We aimed to evaluate whether corticosteroids might improve clinical outcomes in patients with severe CAP and high inflammatory responses.

Study design and methods: We analyzed two prospective observational cohorts of patients with CAP in Barcelona and Rome who were admitted to intensive care with a high inflammatory response. Propensity score (PS) matching was used to obtain balance among the baseline variables in both groups, and we excluded patients with viral pneumonia or who received hydrocortisone.

Results: Of the 610 patients admitted with severe CAP, 198 (32%) received corticosteroids and 387 had major criteria for severe CAP. All patients had a baseline serum C-reactive protein above 15 mg/dL. Patients who received corticosteroids were more commonly male, had more comorbidities (e.g., cancer or chronic obstructive pulmonary disease), and presented with significantly higher sequential organ failure assessment scores. Eighty-nine patients met major severity criteria (invasive mechanical ventilation and/or septic shock) and were matched per group. Twenty-eight-day mortality was lower among patients receiving corticosteroids (16 patients, 18%) than among those not receiving them (28 patients, 31%; p = 0.037). After PS matching, corticosteroid therapy reduced the 28-day mortality risk in patients who met major severity criteria (hazard ratio (HR) 0.53, 95% confidence interval (CI) 0.29-0.98) (p = 0.043). In patients who did not meet major severity criteria, no benefits were observed with corticosteroid use (HR 0.88 (95%CI 0.32-2.36).

Conclusions: Corticosteroid treatment may be of benefit for patients with CAP who have septic shock and/or a high inflammatory response and requirement for invasive mechanical ventilation. Corticosteroids appear to have no impact on mortality when these features are not present.

Keywords: Community-acquired pneumonia; Corticosteroids; Mortality.

PubMed Disclaimer

Conflict of interest statement

The authors have disclosed that they do not have any conflicts of interest.

Figures

Fig. 1
Fig. 1
Flowchart. CAP, community-acquired pneumonia; CRP: C-reactive protein; ICU, intensive care unit; IMV, invasive mechanical ventilation; PS, propensity score
Fig. 2
Fig. 2
Kaplan–Meier survival curve after PS matching
See this image and copyright information in PMC

References

    1. Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet Lond Engl. 2015;386(9998):1097–1108. doi: 10.1016/S0140-6736(15)60733-4. - DOI - PMC - PubMed
    1. Dambrava PG, Torres A, Vallès X, Mensa J, Marcos MA, Peñarroja G, et al. Adherence to guidelines’ empirical antibiotic recommendations and community-acquired pneumonia outcome. Eur Respir J. 2008;32(4):892–901. doi: 10.1183/09031936.00163407. - DOI - PubMed
    1. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250. doi: 10.1056/NEJM199701233360402. - DOI - PubMed
    1. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America. Am J Respir Crit Care Med. 2019;200(7):e45–67. doi: 10.1164/rccm.201908-1581ST. - DOI - PMC - PubMed
    1. Ferrer M, Travierso C, Cilloniz C, Gabarrus A, Ranzani OT, Polverino E, et al. Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients. PLoS ONE. 2018;13(1):e0191721. doi: 10.1371/journal.pone.0191721. - DOI - PMC - PubMed

Publication types

Substances